Neudle.com: dopamine blocking agent

Differential
(Click to cross reference)

acetaminophen

acetylcholine

acquired immunodeficiency syndrome

acrochordon

acromegaly

advances in neurology

adverse drug reaction

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, Parkinson-dementia-complex

analgesic

anatomy of

antibiotics

anticholinergic drugs

anticonvulsants

anticonvulsants, untoward effects of

attention deficit disorder with hyperactivity

atypical

autonomic dysfunction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

carbon monoxide poisoning

carpal tunnel syndrome

caspases

CAT scan, abnormal

catatonia

cerebellar pontine angle

cerebellar pontine angle tumor

cerebral infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebrovascular accident

controversies in neurology

conversion reaction

coprolalia

cost effectiveness

creatine phosphokinase(CPK)elevated

degenerative diseases of CNS

dementia

dementia, cerebrovascular disease causing

dementia, prevention of

depression

DHE

diabetes mellitus

differential diagnosis

dopamine antagonist, peripheral

dopamine depleting agents

dopamine receptor, D2

dopaminergic neurons

droperidol

drug induced neurologic disorders

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia

dystonia, drug induced

dystonia, treatment of

dystonic reaction, acute

emergencies, neurologic

emergency room

encephalitis

encephalitis, Japanese

epidemiology of neurology

eye movement, disorders of

Fahr disease

fever

flavivirus

Gilles de la Tourette syndrome

headache, evaluation of

headache, prophylaxis

headache, treatment of

hearing loss

hemiballismus

hepatolenticular degeneration(Wilson's disease)

highly active antiretroviral therapy

human immunodeficiency virus type 1

hypoxic encephalopathy

iatrogenic neurologic disorders

impotence

impulsivity

iron, brain

Jakob-Creutzfeldt disease

L-dopa

L-dopa, drug interactions with and side effects of

Leigh's disease

leukocytosis

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

lithium

liver disease

lumbar puncture, indications for

migraine, prophylaxis

migraine, treatment of

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, post hemiplegic

movement disorder, treatment of

MRI

MRI, abnormal

MRI, diffusion weighted

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic testing

neuronal cell death

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuroprotective agents

nonsteroidal anti-inflammatory drug

obsessive-compulsive disorder

octreotide

oculogyric crisis

olanzapine

osmotic demyelination syndrome

Parkinson disease, drug induced

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, treatment of

Parkinson disease, young onset

Parkinsonism syndrome

Parkinsonism-dementia complex

pathologic gambling

pathology

patient information and support

pituitary, adenoma, giant

pituitary, microadenoma

practice guidelines

pramipexole

pregnancy, neurologic complications in

prevention of neurologic disorders

psychiatric problems in neurologic disorders

psychosis

psychotic behavior

radiation necrosis

radiation therapy, CNS treatment and complications with

recurrent

renal failure

reserpine and reserpine like drugs

reserpine treatment in movement disorder

review article

rigidity

risk factors

sensorineural hearing loss

serotonin agonist

sinemet

single photon emission computed tomography

skin, lesions in neurologic disorders

sleep apnea

smell

sodium-glucoe cotransporter-2 inhibitors

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

sumatriptan

sweating

symmetric brain lesions

synucleinopathy

tardive akathisia

tardive dyskinesia

tardive dyskinesia, treatment of

tardive dystonia

tardive pain syndrome

tension headache

tetrabenazine

tetracycline

thalamus, lesion of-bilateral

thiothixene

tic

tic, chronic multiple

tic, classification of

treatment of neurologic disorder

Showing articles 3850 to 3882 of 3882 << Previous

Olivopontocerebellar Atrophies:A Review
Medicine 49:227, Konigsmark,B., 1970

Treatment of Encephalitis
Hospital Medicine, pp 88-97, Feb970., Scott,T.F.,et al, 1970

The Neuromyopathy of Vincristine in Man, Clinical, Electrophysiol & Pathological Studies
J Neurol Sci 10:107-131, Bradley,W.G.,et al, 1970

Current Trends in the Chemotherapy of Brain Tumors with Special Reference to Glioblastomas
J Neurosurg 31:589, Wilson,C.,et al, 1969

Progressive Supranuclear Palsy Clinico-Pathological Study of Four Cases
Brain 92:663, Behrman,S.,et al, 1969

Treatment of Strokes
NEJM 281:594, 1969,, Browne,T.,et al, 1969

Vascular Surgery for Cerebrovascular Insufficiency
Current Concepts of CVD 4:Nov, Hass,Wm., 1969

Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969

Treatment of Acute Stroke with Dextran 40
JAMA 210:293, Gilroy,J.,et al, 1969

Effects of Changes in Carbon Dioxide Press & Art Press on Blood Flow in Ischemic Regions of Brain in Dogs
Circ Research, Vol 24, Apr 1969., Kogure,K.,et al, 1969

Atherosclerotic CVD-Its Nature & Management
Am J Med 46:763, Heyden,S.,et al, 1969

Ataxia In Childhood
Dev Med Child Neurol 10:388-389, Wilson,J., 1968

Idiopathic Thrombocytosis
Neurol 18:711-713, Levine,J.,et al, 1968

Corticodentatonigral Degeneration with Neuronal Achromasia
Arch Neurol 18:20-33, Rebeiz,J.J.,et al, 1968

Monocular Diplopia:Its Characteristics & Response to Guanethidine
Am J Ophthalmol 63:459, Hales,R., 1967

Tuberous Sclerosis:Reappraisal of a Clinical Entity
Mayo Clin Proc 42:26, Lagos,J.,et al, 1967

Ocular Complications of Vincristine Therapy
Arch Ophthalmol 78:709, Albert,D.M.,et al, 1967

The Luxury-Perfusion Syndrome & Its Possible Relation to Acute Metabolic Acidosis Localized within the Brain
Lancet Nov 19, Burns,T.,et al, 1966

Diagnosis & Management of Cerebrovascular Disease
Postgrad Med 38:130, Fisher,C.M., 1965

Bacterial Meningitis, A Review of Selected Aspects (Cont. )
NEJM 272:842, Swartz,M.N.,et al, 1965

Acute Hypertensive Cerebellar Hemorrhage:Diagnosis & Surgical Treatment
J Nerv Ment Dis 140:38, Fisher,C.M.,et al, 1965

Improvement in Brain Oxygenation & Clinical Improvement in Patients with Strokes Treated with Papaverine Hydrochloride
JAMA 194:957, Meyer,J.,et al, 1965

CVA or Subdural Fluid Collection
Arch Int Med 12:966, Feldman,R.,et al, 1963

Occlusive Cerebrovascular Disease
Am J Med 30:577, Meyer,J.S., 1961

Spontaneous Cerebellar Hemorrhage
Brain 83:1, McKissock,W.,et al, 1960

Diseases of the Basal Ganglia-Their Relation to Disorders of Movement
Lancet 1099, 1960, Nov., Denny-Brown,D., 1960

Myasthenic Syndrome in Patients with ALS
et al Neurol 9:627, Mulder,D.W., 1959

Neurologic Manifestations of Chronic Carbon Monoxide Poisoning
NEJM 261:1217-1220, Gilbert,G.J.,et al, 1959

Carbon Monoxide Asphyxia, A Common Clinical Entity
Canad M A J 78:182-185, Katz,M., 1958

Studies in CVDis. The Use of Anticoagulant Drugs in Insufficiency or Thrombosis with the Basilar Art. Sys
Staff Meetings of the Mayo Clinic, 30:1171955., Millikan,C., 1955

Neurologic Effects of Lightning & of Electricity
Lancet l:68, Critchley,M., 1934

MR Mismatch Is Useful for Patient Selection for Thrombolysis: No
Stroke 40:2908-2909,2910, Sch�bitz,W.R.,

Model for Predicting the Risk of Ipsilateral Ischaemic Stroke in Patients with Recently Symptomatic Carotid Bifurcation Stenosis
www.stroke.ox.ac.uk/model/form1.html, ,

Showing articles 3850 to 3882 of 3882 << Previous